GPT Healthcare Limited

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, HEXAWARE.NS has a market cap of 141.4B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while HEXAWARE.NS trades at ₹470.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas HEXAWARE.NS's P/E ratio is 22.98. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to HEXAWARE.NS's ROE of +0.25%. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to HEXAWARE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check HEXAWARE.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, DOMS.BO has a market cap of 138.2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while DOMS.BO trades at ₹2,185.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas DOMS.BO's P/E ratio is 62.50. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to DOMS.BO's ROE of +0.21%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to DOMS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check DOMS.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, SAFARIND.BO has a market cap of 91.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while SAFARIND.BO trades at ₹1,915.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas SAFARIND.BO's P/E ratio is 1394.97. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to SAFARIND.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to SAFARIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check SAFARIND.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ENTERO.NS has a market cap of 48.8B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ENTERO.NS trades at ₹1,126.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ENTERO.NS's P/E ratio is 43.31. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ENTERO.NS's ROE of +0.06%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to ENTERO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ENTERO.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ORIANA.NS has a market cap of 35.5B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ORIANA.NS trades at ₹1,664.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ORIANA.NS's P/E ratio is 21.98. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ORIANA.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to ORIANA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ORIANA.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, MEDIASSIST.NS has a market cap of 24.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while MEDIASSIST.NS trades at ₹312.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas MEDIASSIST.NS's P/E ratio is 41.42. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to MEDIASSIST.NS's ROE of +0.10%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to MEDIASSIST.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check MEDIASSIST.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, RPTECH.NS has a market cap of 22.6B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while RPTECH.NS trades at ₹340.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas RPTECH.NS's P/E ratio is 9.33. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to RPTECH.NS's ROE of +0.14%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to RPTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check RPTECH.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ALPEXSOLAR.NS has a market cap of 19.7B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ALPEXSOLAR.NS trades at ₹743.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ALPEXSOLAR.NS's P/E ratio is 15.11. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ALPEXSOLAR.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to ALPEXSOLAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ALPEXSOLAR.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, AIMTRON.NS has a market cap of 16.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while AIMTRON.NS trades at ₹760.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas AIMTRON.NS's P/E ratio is 59.90. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to AIMTRON.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to AIMTRON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check AIMTRON.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, VMARCIND.NS has a market cap of 15.9B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while VMARCIND.NS trades at ₹611.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas VMARCIND.NS's P/E ratio is 26.31. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to VMARCIND.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to VMARCIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check VMARCIND.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, GRNLAMIND.BO has a market cap of 13.4B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while GRNLAMIND.BO trades at ₹556.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas GRNLAMIND.BO's P/E ratio is 19.03. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to GRNLAMIND.BO's ROE of -0.01%. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to GRNLAMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check GRNLAMIND.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ASHIKA.BO has a market cap of 13.4B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ASHIKA.BO trades at ₹334.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ASHIKA.BO's P/E ratio is -26.78. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ASHIKA.BO's ROE of +0.02%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to ASHIKA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ASHIKA.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, VILAS.NS has a market cap of 9.4B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while VILAS.NS trades at ₹378.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas VILAS.NS's P/E ratio is 20.74. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to VILAS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to VILAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check VILAS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, TAC.NS has a market cap of 9.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while TAC.NS trades at ₹418.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas TAC.NS's P/E ratio is 63.66. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to TAC.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to TAC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check TAC.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, DPEL.NS has a market cap of 8.9B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while DPEL.NS trades at ₹403.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas DPEL.NS's P/E ratio is 91.41. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to DPEL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to DPEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check DPEL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ACCENTMIC.NS has a market cap of 8.6B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ACCENTMIC.NS trades at ₹347.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ACCENTMIC.NS's P/E ratio is 24.13. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ACCENTMIC.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to ACCENTMIC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ACCENTMIC.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, SARTELE.NS has a market cap of 8.2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while SARTELE.NS trades at ₹154.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas SARTELE.NS's P/E ratio is 10.40. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to SARTELE.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to SARTELE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check SARTELE.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, REMUS.NS has a market cap of 7.7B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while REMUS.NS trades at ₹634.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas REMUS.NS's P/E ratio is 18.17. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to REMUS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to REMUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check REMUS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ZTECH.NS has a market cap of 6.5B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ZTECH.NS trades at ₹498.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ZTECH.NS's P/E ratio is 30.81. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ZTECH.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to ZTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ZTECH.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, DENTALKART.NS has a market cap of 6.4B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while DENTALKART.NS trades at ₹384.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas DENTALKART.NS's P/E ratio is 38.00. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to DENTALKART.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to DENTALKART.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check DENTALKART.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, GGBL.NS has a market cap of 6.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while GGBL.NS trades at ₹248.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas GGBL.NS's P/E ratio is 13.04. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to GGBL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to GGBL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check GGBL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, KILPEST.BO has a market cap of 6.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while KILPEST.BO trades at ₹808.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas KILPEST.BO's P/E ratio is 18.32. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to KILPEST.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to KILPEST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check KILPEST.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, APS.NS has a market cap of 6.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while APS.NS trades at ₹293.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas APS.NS's P/E ratio is 14.86. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to APS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to APS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check APS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, PCCL.NS has a market cap of 6.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while PCCL.NS trades at ₹236.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas PCCL.NS's P/E ratio is 64.22. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to PCCL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to PCCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check PCCL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, KRITIIND.BO has a market cap of 5.8B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while KRITIIND.BO trades at ₹117.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas KRITIIND.BO's P/E ratio is 31.62. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to KRITIIND.BO's ROE of -0.05%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to KRITIIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check KRITIIND.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, BAHETI.NS has a market cap of 5.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while BAHETI.NS trades at ₹498.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas BAHETI.NS's P/E ratio is 29.62. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to BAHETI.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to BAHETI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check BAHETI.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, EFFWA.NS has a market cap of 4.7B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while EFFWA.NS trades at ₹196.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas EFFWA.NS's P/E ratio is 23.59. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to EFFWA.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to EFFWA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check EFFWA.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, VIVIANA.NS has a market cap of 4.2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while VIVIANA.NS trades at ₹642.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas VIVIANA.NS's P/E ratio is 33.57. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to VIVIANA.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to VIVIANA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check VIVIANA.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, SJLOGISTIC.NS has a market cap of 4.2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while SJLOGISTIC.NS trades at ₹260.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas SJLOGISTIC.NS's P/E ratio is 7.77. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to SJLOGISTIC.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to SJLOGISTIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check SJLOGISTIC.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, BASILIC.NS has a market cap of 4.2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while BASILIC.NS trades at ₹174.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas BASILIC.NS's P/E ratio is 11.12. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to BASILIC.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to BASILIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check BASILIC.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, SUPREMEPWR.NS has a market cap of 4.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while SUPREMEPWR.NS trades at ₹156.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas SUPREMEPWR.NS's P/E ratio is 19.75. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to SUPREMEPWR.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to SUPREMEPWR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check SUPREMEPWR.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, KOTYARK.NS has a market cap of 3.8B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while KOTYARK.NS trades at ₹366.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas KOTYARK.NS's P/E ratio is 26.52. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to KOTYARK.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to KOTYARK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check KOTYARK.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, VISHNUINFR.NS has a market cap of 3.5B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while VISHNUINFR.NS trades at ₹148.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas VISHNUINFR.NS's P/E ratio is 12.02. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to VISHNUINFR.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to VISHNUINFR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check VISHNUINFR.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, WSIND.BO has a market cap of 3.5B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while WSIND.BO trades at ₹131.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas WSIND.BO's P/E ratio is -6.02. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to WSIND.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to WSIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check WSIND.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, MOS.NS has a market cap of 3.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while MOS.NS trades at ₹11.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas MOS.NS's P/E ratio is 23.45. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to MOS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to MOS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check MOS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ATMASTCO.NS has a market cap of 3.2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ATMASTCO.NS trades at ₹120.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ATMASTCO.NS's P/E ratio is 16.56. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ATMASTCO.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to ATMASTCO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ATMASTCO.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, SEJAL.BO has a market cap of 3.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while SEJAL.BO trades at ₹307.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas SEJAL.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to SEJAL.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to SEJAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check SEJAL.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, TRANSTEEL.NS has a market cap of 3.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while TRANSTEEL.NS trades at ₹135.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas TRANSTEEL.NS's P/E ratio is 22.70. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to TRANSTEEL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to TRANSTEEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check TRANSTEEL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, HIGREEN.NS has a market cap of 3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while HIGREEN.NS trades at ₹118.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas HIGREEN.NS's P/E ratio is 28.55. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to HIGREEN.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to HIGREEN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check HIGREEN.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ANNAPURNA.NS has a market cap of 2.9B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ANNAPURNA.NS trades at ₹150.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ANNAPURNA.NS's P/E ratio is 13.10. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ANNAPURNA.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to ANNAPURNA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ANNAPURNA.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, INFOLLION.NS has a market cap of 2.8B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while INFOLLION.NS trades at ₹284.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas INFOLLION.NS's P/E ratio is 20.49. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to INFOLLION.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to INFOLLION.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check INFOLLION.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, RBMINFRA.NS has a market cap of 2.8B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while RBMINFRA.NS trades at ₹313.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas RBMINFRA.NS's P/E ratio is 11.79. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to RBMINFRA.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to RBMINFRA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check RBMINFRA.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, YASHOPTICS.NS has a market cap of 2.6B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while YASHOPTICS.NS trades at ₹105.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas YASHOPTICS.NS's P/E ratio is 32.39. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to YASHOPTICS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to YASHOPTICS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check YASHOPTICS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, GSMFOILS.NS has a market cap of 2.6B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while GSMFOILS.NS trades at ₹195.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas GSMFOILS.NS's P/E ratio is 16.25. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to GSMFOILS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to GSMFOILS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check GSMFOILS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, LAKSHVILAS.NS has a market cap of 2.6B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while LAKSHVILAS.NS trades at ₹7.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas LAKSHVILAS.NS's P/E ratio is -0.34. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to LAKSHVILAS.NS's ROE of -0.54%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to LAKSHVILAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check LAKSHVILAS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, PHANTOMFX.NS has a market cap of 2.5B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while PHANTOMFX.NS trades at ₹177.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas PHANTOMFX.NS's P/E ratio is 8.83. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to PHANTOMFX.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to PHANTOMFX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check PHANTOMFX.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, MASON.NS has a market cap of 2.5B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while MASON.NS trades at ₹135.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas MASON.NS's P/E ratio is 73.44. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to MASON.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to MASON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check MASON.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, FELIX.NS has a market cap of 2.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while FELIX.NS trades at ₹166.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas FELIX.NS's P/E ratio is 16.16. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to FELIX.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to FELIX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check FELIX.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, AKSCHEM.BO has a market cap of 2.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while AKSCHEM.BO trades at ₹281.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas AKSCHEM.BO's P/E ratio is 19.24. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to AKSCHEM.BO's ROE of +0.02%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to AKSCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check AKSCHEM.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, AVPINFRA.NS has a market cap of 2.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while AVPINFRA.NS trades at ₹89.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas AVPINFRA.NS's P/E ratio is 19.10. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to AVPINFRA.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to AVPINFRA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check AVPINFRA.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, PRATHAM.NS has a market cap of 2.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while PRATHAM.NS trades at ₹114.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas PRATHAM.NS's P/E ratio is 15.20. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to PRATHAM.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to PRATHAM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check PRATHAM.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, GIRRESORTS.NS has a market cap of 2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while GIRRESORTS.NS trades at ₹113.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas GIRRESORTS.NS's P/E ratio is 3788.33. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to GIRRESORTS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to GIRRESORTS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check GIRRESORTS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, MNKCMILTD.BO has a market cap of 2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while MNKCMILTD.BO trades at ₹29.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas MNKCMILTD.BO's P/E ratio is 125.80. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to MNKCMILTD.BO's ROE of +0.14%. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to MNKCMILTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check MNKCMILTD.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, MNKALCOLTD.BO has a market cap of 1.8B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while MNKALCOLTD.BO trades at ₹27.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas MNKALCOLTD.BO's P/E ratio is -52.02. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to MNKALCOLTD.BO's ROE of +0.03%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to MNKALCOLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check MNKALCOLTD.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, SPCL.NS has a market cap of 1.8B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while SPCL.NS trades at ₹70.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas SPCL.NS's P/E ratio is 15.04. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to SPCL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to SPCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check SPCL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, LAWSIKHO.NS has a market cap of 1.8B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while LAWSIKHO.NS trades at ₹110.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas LAWSIKHO.NS's P/E ratio is 16.33. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to LAWSIKHO.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to LAWSIKHO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check LAWSIKHO.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, TUNWAL.NS has a market cap of 1.7B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while TUNWAL.NS trades at ₹28.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas TUNWAL.NS's P/E ratio is 12.84. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to TUNWAL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to TUNWAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check TUNWAL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, UVSL.NS has a market cap of 1.7B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while UVSL.NS trades at ₹0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas UVSL.NS's P/E ratio is -0.35. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to UVSL.NS's ROE of +0.47%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to UVSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check UVSL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ITCONS.BO has a market cap of 1.4B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ITCONS.BO trades at ₹269.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ITCONS.BO's P/E ratio is 98.82. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ITCONS.BO's ROE of +0.12%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to ITCONS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ITCONS.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, AREYDRG.BO has a market cap of 1.4B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while AREYDRG.BO trades at ₹61.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas AREYDRG.BO's P/E ratio is 28.51. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to AREYDRG.BO's ROE of +0.02%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to AREYDRG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check AREYDRG.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, AURDIS.NS has a market cap of 1.4B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while AURDIS.NS trades at ₹140.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas AURDIS.NS's P/E ratio is 14.22. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to AURDIS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to AURDIS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check AURDIS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, WINSOL.NS has a market cap of 1.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while WINSOL.NS trades at ₹114.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas WINSOL.NS's P/E ratio is 11.11. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to WINSOL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to WINSOL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check WINSOL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, KCEIL.NS has a market cap of 1.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while KCEIL.NS trades at ₹108.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas KCEIL.NS's P/E ratio is 7.51. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to KCEIL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to KCEIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check KCEIL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, DENEERS.NS has a market cap of 1.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while DENEERS.NS trades at ₹154.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas DENEERS.NS's P/E ratio is 8.02. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to DENEERS.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to DENEERS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check DENEERS.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, DIGIKORE.NS has a market cap of 1.3B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while DIGIKORE.NS trades at ₹72.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas DIGIKORE.NS's P/E ratio is -24.47. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to DIGIKORE.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to DIGIKORE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check DIGIKORE.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, KCK.NS has a market cap of 1.2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while KCK.NS trades at ₹17.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas KCK.NS's P/E ratio is 57.06. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to KCK.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to KCK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check KCK.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, WOMANCART.NS has a market cap of 1.2B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while WOMANCART.NS trades at ₹159.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas WOMANCART.NS's P/E ratio is 11.77. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to WOMANCART.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to WOMANCART.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check WOMANCART.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, TBI.NS has a market cap of 1.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while TBI.NS trades at ₹60.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas TBI.NS's P/E ratio is 8.20. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to TBI.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to TBI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check TBI.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, GREENCHEF.NS has a market cap of 1.1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while GREENCHEF.NS trades at ₹44.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas GREENCHEF.NS's P/E ratio is 18.57. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to GREENCHEF.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to GREENCHEF.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check GREENCHEF.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, IEML.NS has a market cap of 1B. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while IEML.NS trades at ₹72.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas IEML.NS's P/E ratio is 6.18. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to IEML.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to IEML.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check IEML.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, OLIL.NS has a market cap of 996.7M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while OLIL.NS trades at ₹319.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas OLIL.NS's P/E ratio is 72.21. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to OLIL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to OLIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check OLIL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, RILINFRA.NS has a market cap of 702.3M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while RILINFRA.NS trades at ₹35.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas RILINFRA.NS's P/E ratio is 14.98. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to RILINFRA.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to RILINFRA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check RILINFRA.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, VBCFERROQ.BO has a market cap of 695M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while VBCFERROQ.BO trades at ₹42.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas VBCFERROQ.BO's P/E ratio is -2.60. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to VBCFERROQ.BO's ROE of +0.02%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to VBCFERROQ.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check VBCFERROQ.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, GGDANDE.BO has a market cap of 684.9M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while GGDANDE.BO trades at ₹143.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas GGDANDE.BO's P/E ratio is -21.46. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to GGDANDE.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to GGDANDE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check GGDANDE.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, CIMMCO.NS has a market cap of 600.3M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while CIMMCO.NS trades at ₹21.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas CIMMCO.NS's P/E ratio is 1.59. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to CIMMCO.NS's ROE of +0.16%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to CIMMCO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check CIMMCO.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, NIRMAN.NS has a market cap of 554.1M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while NIRMAN.NS trades at ₹43.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas NIRMAN.NS's P/E ratio is 1.30. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to NIRMAN.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to NIRMAN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check NIRMAN.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, KONSTELEC.NS has a market cap of 466.6M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while KONSTELEC.NS trades at ₹30.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas KONSTELEC.NS's P/E ratio is 18.07. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to KONSTELEC.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to KONSTELEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check KONSTELEC.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, TRELCHE-B.BO has a market cap of 392.2M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while TRELCHE-B.BO trades at ₹20.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas TRELCHE-B.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to TRELCHE-B.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to TRELCHE-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check TRELCHE-B.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, PINCON.NS has a market cap of 329.8M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while PINCON.NS trades at ₹6.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas PINCON.NS's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to PINCON.NS's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. GPTHEALTH.NS has daily volatility of 2.11 and PINCON.NS has daily volatility of N/A.Check PINCON.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, PRECISION.NS has a market cap of 192.9M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while PRECISION.NS trades at ₹8.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas PRECISION.NS's P/E ratio is 24.00. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to PRECISION.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to PRECISION.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check PRECISION.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ESSARSEC.BO has a market cap of 159.6M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ESSARSEC.BO trades at ₹11.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ESSARSEC.BO's P/E ratio is -71.60. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ESSARSEC.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to ESSARSEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ESSARSEC.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, INNOVATIVE.NS has a market cap of 101.7M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while INNOVATIVE.NS trades at ₹161.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas INNOVATIVE.NS's P/E ratio is 0.29. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to INNOVATIVE.NS's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. GPTHEALTH.NS has daily volatility of 2.11 and INNOVATIVE.NS has daily volatility of N/A.Check INNOVATIVE.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, KTL.NS has a market cap of 83.4M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while KTL.NS trades at ₹4.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas KTL.NS's P/E ratio is 1.25. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to KTL.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to KTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check KTL.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, SAHAJ.NS has a market cap of 56M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while SAHAJ.NS trades at ₹4.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas SAHAJ.NS's P/E ratio is 5.90. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to SAHAJ.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to SAHAJ.NS. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check SAHAJ.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, NAKODA.NS has a market cap of 30M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while NAKODA.NS trades at ₹0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas NAKODA.NS's P/E ratio is 0.04. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to NAKODA.NS's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. GPTHEALTH.NS has daily volatility of 2.11 and NAKODA.NS has daily volatility of N/A.Check NAKODA.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ZSARVAMA.BO has a market cap of 13.1M. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ZSARVAMA.BO trades at ₹52.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ZSARVAMA.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ZSARVAMA.BO's ROE of +0.01%. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to ZSARVAMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ZSARVAMA.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, TVOLCON.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while TVOLCON.BO trades at ₹12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas TVOLCON.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to TVOLCON.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to TVOLCON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check TVOLCON.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ZSATYASL.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ZSATYASL.BO trades at ₹3.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ZSATYASL.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ZSATYASL.BO's ROE of +0.02%. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to ZSATYASL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ZSATYASL.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, DEEPIND.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while DEEPIND.BO trades at ₹249.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas DEEPIND.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to DEEPIND.BO's ROE of +0.10%. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to DEEPIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check DEEPIND.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, VSDCONF.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while VSDCONF.BO trades at ₹5.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas VSDCONF.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to VSDCONF.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to VSDCONF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check VSDCONF.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, JSLL-ST.NS has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while JSLL-ST.NS trades at ₹1,100.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas JSLL-ST.NS's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to JSLL-ST.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to JSLL-ST.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check JSLL-ST.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ZPRBHSTE.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ZPRBHSTE.BO trades at ₹179.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ZPRBHSTE.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ZPRBHSTE.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to ZPRBHSTE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ZPRBHSTE.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, BENTCOM.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while BENTCOM.BO trades at ₹4.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas BENTCOM.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to BENTCOM.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to BENTCOM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check BENTCOM.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, SRPL-RE.NS has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while SRPL-RE.NS trades at ₹0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas SRPL-RE.NS's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to SRPL-RE.NS's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is less volatile compared to SRPL-RE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check SRPL-RE.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ASUTENT.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ASUTENT.BO trades at ₹0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ASUTENT.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ASUTENT.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to ASUTENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ASUTENT.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, GDTRAGN.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while GDTRAGN.BO trades at ₹21.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas GDTRAGN.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to GDTRAGN.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to GDTRAGN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check GDTRAGN.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, E1AIRTELPP.NS has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while E1AIRTELPP.NS trades at ₹1,061.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas E1AIRTELPP.NS's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to E1AIRTELPP.NS's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. GPTHEALTH.NS has daily volatility of 2.11 and E1AIRTELPP.NS has daily volatility of N/A.Check E1AIRTELPP.NS's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, EVERTEX.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while EVERTEX.BO trades at ₹64.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas EVERTEX.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to EVERTEX.BO's ROE of N/A. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to EVERTEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check EVERTEX.BO's competition here

GPTHEALTH.NS plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GPTHEALTH.NS stands at 9.9B. In comparison, ALNATRD.BO has a market cap of 0. Regarding current trading prices, GPTHEALTH.NS is priced at ₹121.00, while ALNATRD.BO trades at ₹28.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GPTHEALTH.NS currently has a P/E ratio of 24.42, whereas ALNATRD.BO's P/E ratio is N/A. In terms of profitability, GPTHEALTH.NS's ROE is +0.17%, compared to ALNATRD.BO's ROE of +0.02%. Regarding short-term risk, GPTHEALTH.NS is more volatile compared to ALNATRD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for GPTHEALTH.NS.Check ALNATRD.BO's competition here